AKT1 and colorectal carcinoma: The simultaneous activations of the pathways of ACLy and PI3K/Akt, the latter of which regulates both glucose and lipid metabolism as well as ACLy levels and activity after being phosphorylated [117], were identified as being crucial in conferring resistance to the topoisomerase I inhibitor SN38 in CRC cells.